VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Quantum BioPharma Ltd. (QNTM) Total Return Calculator with Dividends Reinvested

Quantum BioPharma Ltd.

Popular:

The total return for Quantum BioPharma Ltd. (QNTM) stock is -44.16% over the past 12 months. So far it's down 30.39% this year. The 5-year total return is -95.25%, meaning $10,000 invested in QNTM stock 5 years ago would be worth $475 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in QNTM 1 year ago, it would be worth $5,584 today — you'd have lost $4,416.

With Dividends Reinvested$5,584-44.16%

Price Only (No DRIP)$5,584-44.16%

Period2025-05-08 → 2026-05-08

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in QNTM

1Y$5,584-$4,416 (-44.2%)-44.2% CAGR

3Y$615-$9,385 (-93.8%)-60.5% CAGR

5Y$475-$9,525 (-95.2%)-45.6% CAGR

10Y$43-$9,957 (-99.6%)-42.0% CAGR

15Y$43-$9,957 (-99.6%)-30.4% CAGR

20Y$43-$9,957 (-99.6%)-23.8% CAGR

30Y$43-$9,957 (-99.6%)-16.6% CAGR

Quantum BioPharma Ltd. did not pay dividends during this period. Total return = price return.

Loading QNTM total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-30.39%	—	-30.39%	—	$6,961
1Y	-44.16%	-44.16%	-44.16%	—	$5,584
3Y	-93.85%	-60.52%	-93.85%	—	$615
5Y	-95.25%	-45.63%	-95.25%	—	$475
10Y	-99.57%	-41.95%	-99.57%	—	$43
15Y	-99.57%	-30.41%	-99.57%	—	$43
20Y	-99.57%	-23.81%	-99.57%	—	$43
30Y	-99.57%	-16.58%	-99.57%	—	$43

Risk & Highlights

Best Year+148.84%2018

Worst Year-93.71%2024

Max Drawdown-94.00%2025-06-20 → 2026-03-11

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-49.36%	-49.36%	—	+0.41%	-49.8pp
2025	+78.92%	+78.92%	—	+16.64%	+62.3pp
2024	-93.71%	-93.71%	—	+24.00%	-117.7pp
2023	+19.15%	+19.15%	—	+24.81%	-5.7pp
2022	-26.31%	-26.31%	—	-19.95%	-6.4pp

QNTM underperformed the S&P 500 by 74.70pp over the past year (-44.16% vs +30.54%).

Loading summary...

QNTM Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
QNTMQuantum BioPharma Ltd.	$22M	+32.6%	-30.4%	-44.2%	—	-93.8%	-95.2%	-99.6%
SAVACassava Sciences, Inc.	$94M	—	-6.5%	+15.0%	—	-40.8%	-64.6%	-19.5%
ANVSAnnovis Bio, Inc.	$62M	-0.9%	-37.5%	+42.5%	—	-84.6%	-92.0%	-76.2%
NRXPNRx Pharmaceuticals, Inc.	$85M	+36.9%	+17.6%	+50.2%	—	-50.3%	-99.0%	-96.8%
MNMDMind Medicine (MindMed) Inc.	$2.0B	—	+51.7%	+220.3%	—	+510.3%	-55.1%	+512.1%
CMPSCOMPASS Pathways plc	$952M	+73.3%	+51.3%	+163.6%	—	+17.1%	-72.3%	-65.8%
ATAIAtai Beckley N.V	$969M	+7.2%	+4.1%	+187.9%	—	+100.5%	-79.7%	-47.6%
CYBNCybin Inc.	$304M	—	-26.4%	-8.1%	—	-49.8%	-90.2%	-99.7%
LWAYLifeway Foods, Inc.	$390M	+11.3%	+12.3%	+6.5%	—	+326.7%	+461.4%	+166.7%
ABBVAbbVie Inc.	$356.5B	-4.9%	-10.6%	+12.2%	+3.6pp	+49.7%	+99.6%	+293.8%
JNJJohnson & Johnson	$533.4B	-8.3%	+7.4%	+45.5%	+3.3pp	+45.5%	+43.9%	+131.3%

Compare:QNTM vs SAVA QNTM vs ANVS QNTM vs NRXP QNTM vs SAVA vs ANVS

About QNTM Dividend Returns

Quantum BioPharma Ltd. (QNTM) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of QNTM over the past year?

Quantum BioPharma Ltd. (QNTM) delivered a return of -44.16% over the past year. Since QNTM does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in QNTM be worth today?

A $10,000 investment in Quantum BioPharma Ltd. one year ago would be worth $5,584 today, representing a loss of $4,416.

Q3Does QNTM pay dividends?

Quantum BioPharma Ltd. (QNTM) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For QNTM, the total return equals the price-only return.

Q4Did QNTM beat the S&P 500?

No, Quantum BioPharma Ltd. (QNTM) underperformed the S&P 500 by 74.70 percentage points over the past year. QNTM delivered a total return of -44.16%, compared to the S&P 500's 30.54%. This means a passive S&P 500 index fund outperformed QNTM by 74.70pp during this period.

Q5What is QNTM's worst drawdown?

Quantum BioPharma Ltd. (QNTM) experienced a maximum drawdown of -94.00% over the past year, declining from its peak on 2025-06-20 to its trough on 2026-03-11. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is QNTM's long-term total return over 10, 20, or 30 years?

Here are Quantum BioPharma Ltd. (QNTM)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.6% (-42.0% CAGR) — $10,000 would have grown to $43. Over 20 years: -99.6% total return (-23.8% CAGR) — $10,000 → $43. Over 30 years: -99.6% total return (-16.6% CAGR) — $10,000 → $43. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was QNTM's best and worst year?

Quantum BioPharma Ltd.'s best calendar year was 2018 with a total return of 148.8%. Its worst year was 2024 with a total return of -93.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 242.5 percentage points.